Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


19.08.2019

1 Antimicrob Agents Chemother
1 Clin Infect Dis
8 Emerg Infect Dis
14 Int J Antimicrob Agents
3 J Infect Chemother
4 J Med Microbiol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. JIA X, Ren H, Nie X, Li Y, et al
    Antibiotic resistance and azithromycin resistance mechanism of Legionella pneumophila serogroup 1 in China.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00768.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. JORGENSEN SCJ, Zasowski EJ, Trinh TD, Lagnf AM, et al
    Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.
    Clin Infect Dis. 2019 Aug 12. pii: 5548921. doi: 10.1093.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  3. EL ACHKAR S, Demanche C, Osman M, Rafei R, et al
    Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.
    Emerg Infect Dis. 2019;25:564-568.
    PubMed     Text format     Abstract available

  4. LIPWORTH S, Jajou R, de Neeling A, Bradley P, et al
    SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
    Emerg Infect Dis. 2019;25:482-488.
    PubMed     Text format     Abstract available

  5. HARE RK, Gertsen JB, Astvad KMT, Degn KB, et al
    In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) in Aspergillus fumigatus cyp51A, Denmark.
    Emerg Infect Dis. 2019;25:577-580.
    PubMed     Text format     Abstract available

  6. BOUZOUITA I, Cabibbe AM, Trovato A, Daroui H, et al
    Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
    Emerg Infect Dis. 2019;25:538-546.
    PubMed     Text format     Abstract available

  7. LEPUSCHITZ S, Ruppitsch W, Pekard-Amenitsch S, Forsythe SJ, et al
    Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017.
    Emerg Infect Dis. 2019;25:515-522.
    PubMed     Text format     Abstract available

  8. BROWNE AS, Biggs PJ, Wilkinson DA, Cookson AL, et al
    Use of Genomics to Investigate Historical Importation of Shiga Toxin-Producing Escherichia coli Serogroup O26 and Nontoxigenic Variants into New Zealand.
    Emerg Infect Dis. 2019;25:489-500.
    PubMed     Text format     Abstract available

  9. SKIBA Y, Mokrousov I, Nabirova D, Vyazovaya A, et al
    Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
    Emerg Infect Dis. 2019;25:604-606.
    PubMed     Text format     Abstract available

  10. PARK JY, Bradley N, Brooks S, Burney S, et al
    Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018(1).
    Emerg Infect Dis. 2019;25:601-602.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  11. SAIDANI N, Lagier JC, Cassir N, Million M, et al
    Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.
    Int J Antimicrob Agents. 2019;53:355-361.
    PubMed     Text format     Abstract available

  12. VISCA P, Pisa F, Imperi F
    The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.
    Int J Antimicrob Agents. 2019;53:449-455.
    PubMed     Text format     Abstract available

  13. DURAND GA, Raoult D, Dubourg G
    Antibiotic discovery: history, methods and perspectives.
    Int J Antimicrob Agents. 2019;53:371-382.
    PubMed     Text format     Abstract available

  14. DE LA CALLE C, Rodriguez O, Morata L, Marco F, et al
    Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    Int J Antimicrob Agents. 2019;53:520-524.
    PubMed     Text format     Abstract available

  15. KARLOWSKY JA, Hackel MA, Tsuji M, Yamano Y, et al
    In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
    Int J Antimicrob Agents. 2019;53:456-466.
    PubMed     Text format     Abstract available

  16. BASSETTI M, Castaldo N, Cattelan A, Mussini C, et al
    Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
    Int J Antimicrob Agents. 2019;53:408-415.
    PubMed     Text format     Abstract available

  17. ZHANG X, Li Y, Wang W, Zhang J, et al
    Identification of an anti-Gram-negative bacteria agent disrupting the interaction between lipopolysaccharide transporters LptA and LptC.
    Int J Antimicrob Agents. 2019;53:442-448.
    PubMed     Text format     Abstract available

  18. COUVE-DEACON E, Jove T, Afouda P, Barraud O, et al
    Class 1 integrons in Acinetobacter baumannii: a weak expression of gene cassettes to counterbalance the lack of LexA-driven integrase repression.
    Int J Antimicrob Agents. 2019;53:491-499.
    PubMed     Text format     Abstract available

  19. ABBARA S, Pitsch A, Jochmans S, Hodjat K, et al
    Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Int J Antimicrob Agents. 2019;53:416-422.
    PubMed     Text format     Abstract available

  20. PIEWNGAM P, Quinones M, Thirakittiwatthana W, Yungyuen T, et al
    Composition of the intestinal microbiota in extended-spectrum beta-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Int J Antimicrob Agents. 2019;53:435-441.
    PubMed     Text format     Abstract available

  21. LUNA BL, Garcia JA, Huang M, Ewing PJ, et al
    Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
    Int J Antimicrob Agents. 2019;53:474-482.
    PubMed     Text format     Abstract available

  22. ZENG S, Meng X, Huang Q, Lei N, et al
    Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
    Int J Antimicrob Agents. 2019;53:362-369.
    PubMed     Text format     Abstract available

  23. TRAGLIA GM, Place K, Dotto C, Fernandez JS, et al
    Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain.
    Int J Antimicrob Agents. 2019;53:483-490.
    PubMed     Text format     Abstract available

  24. STERRANTINO G, Borghi V, Callegaro AP, Bruzzone B, et al
    Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors.
    Int J Antimicrob Agents. 2019;53:515-519.
    PubMed     Text format     Abstract available


    J Infect Chemother

  25. KO JH, Jung DS, Lee JY, Kim HA, et al
    Changing epidemiology of non-albicans candidemia in Korea.
    J Infect Chemother. 2019;25:388-391.
    PubMed     Text format     Abstract available

  26. HARA N, Wajima T, Seyama S, Tanaka E, et al
    Isolation of multidrug-resistant Haemophilus influenzae harbouring multiple exogenous genes from a patient diagnosed with acute sinusitis.
    J Infect Chemother. 2019;25:385-387.
    PubMed     Text format     Abstract available

  27. OKUMURA T, Kawada JI, Tanaka M, Narita K, et al
    Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children.
    J Infect Chemother. 2019;25:346-350.
    PubMed     Text format     Abstract available


    J Med Microbiol

  28. HARE KM, Seib KL, Chang AB, Harris TM, et al
    Antimicrobial susceptibility and impact of macrolide antibiotics on Moraxella catarrhalis in the upper and lower airways of children with chronic endobronchial suppuration.
    J Med Microbiol. 2019;68:1140-1147.
    PubMed     Text format     Abstract available

  29. BELDA-ORLOWSKI A, Pfennigwerth N, Gatermann SG, Korte-Berwanger M, et al
    Evaluation and readout optimization of the rapid polymyxin NP test for the detection of colistin-resistant Enterobacteriaceae.
    J Med Microbiol. 2019;68:1189-1193.
    PubMed     Text format     Abstract available

  30. TANAKA E, Wajima T, Noguchi N
    Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
    J Med Microbiol. 2019;68:1227-1232.
    PubMed     Text format     Abstract available

  31. DOLZANI L, Milan A, Scocchi M, Lagatolla C, et al
    Sub-MIC effects of a proline-rich antibacterial peptide on clinical isolates of Acinetobacter baumannii.
    J Med Microbiol. 2019;68:1253-1265.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: